References
- Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global Strategy for the Diagnosis, Management and Prevention of COPD; 2015 [cited 2019 Aug 8]. Available from: http://goldcopd.org.
- Global Initiative for Asthma (GINA): Global Strategy for Asthma Management and Prevention; 2019 [cited 2019 Aug 11]. Available from: https://ginasthma.org.
- GINA & GOLD: Diagnosis of Diseases of Chronic Airflow Limitation: Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS); 2015 [cited 2019 Aug 11]. Available from: https://goldcopd.org/asthma-copd-asthma-copd-overlap-syndrome/.
- Andersen H, Lampela P, Nevanlinna A, et al. High hospital burden in overlap syndrome of asthma and COPD. Clin Respir J. 2013;7(4):342–346. doi:10.1111/crj.12013.
- Leung JM, Sin DD. Asthma-COPD overlap syndrome: pathogenesis, clinical features, and therapeutic targets. BMJ. 2017;358:j3772. doi:10.1136/bmj.j3772.
- Alshabanat A, Zafari Z, Albanyan O, et al. Asthma and COPD Overlap Syndrome (ACOS): a systematic review and meta analysis. PLoS One. 2015;10(9):e0136065. doi:10.1371/journal.pone.0136065.
- Pavord ID, Jones PW, Burgel PR, et al. Exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2016;11 Spec Iss:21–30.
- Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez PF, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. doi:10.1136/thx.2005.040527.
- Garcia-Sanz MT, Canive-Gomez JC, Senin-Rial L, et al. One-year and long-term mortality in patients hospitalized for chronic obstructive pulmonary disease. J Thorac Dis. 2017;9:636–645.
- Divo M, Cote C, de Torres JP, BODE Collaborative Group, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155–161. doi:10.1164/rccm.201201-0034OC.
- Maselli DJ, Hanania NA. Asthma COPD overlap: impact of associated comorbidities. Pulm Pharmacol Ther. 2018;52:27–31. doi:10.1016/j.pupt.2018.08.006.
- Golpe R, Suarez-Valor M, Martin-Robles I, et al. Mortality in COPD patients according to clinical phenotypes. Int J Chron Obstruct Pulmon Dis. 2018;13:1433–1439. doi:10.2147/COPD.S159834.
- Park HY, Lee SY, Kang D, et al. Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort. Respir Res. 2018;19(1):36. doi:10.1186/s12931-018-0737-8.
- Mendy A, Forno E, Niyonsenga T, et al. Prevalence and features of asthma-COPD overlap in the United States 2007-2012. Clin Respir J. 2018;12(8):2369–2377. doi:10.1111/crj.12917.
- Kim MH, Rhee CK, Kim K, et al. Heterogeneity of asthma and COPD overlap. COPD. 2018;13:1251–1260. doi:10.2147/COPD.S152916.
- Suzuki M, Makita H, Konno S, et al. Asthma-like features and clinical course of chronic obstructive pulmonary disease. an analysis from the Hokkaido COPD cohort study. Am J Respir Crit Care Med. 2016;194(11):1358–1365. doi:10.1164/rccm.201602-0353OC.
- Toledo-Pons N, van Boven JFM, Román-Rodriguez M, et al. ACO: time to move from the description of different phenotypes to the treatable traits. PLoS One. 2019;14(1):e0210915. doi:10.1371/journal.pone.0210915.
- O'Byrne P, Fabbri LM, Pavord ID, et al. Asthma progression and mortality: the role of inhaled corticosteroids. Eur Respir J. 2019;54(1):1900491. doi:10.1183/13993003.00491-2019.
- Young RP, Hopkins RJ, Christmas T, et al. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009;34(2):380–386. doi:10.1183/09031936.00144208.
- Sandelin M, Mindus S, Thuresson M, et al. Factors associated with lung cancer in COPD patients. Int J Chron Obstruct Pulmon Dis. 2018;13:1833–1839. doi:10.2147/COPD.S162484.
- Fabbri LM, Luppi F, Beghé B, et al. Complex chronic comorbidities of COPD. Eur Respir J. 2008;31(1):204–212. doi:10.1183/09031936.00114307.
- McGarvey LP, Magder S, Burkhart D, et al. Cause-specific mortality adjudication in the UPLIFT® COPD trial: findings and recommendations. Respir Med. 2012;106(4):515–521. doi:10.1016/j.rmed.2011.10.009.
- Gudmundsson G, Ulrik CS, Gislason T, et al. Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries. Int J Chron Obstruct Pulmon Dis. 2012;7:571–576.
- Pinto LM, Alghamdi M, Benedetti A, et al. Derivation and validation of clinical phenotypes for COPD: a systematic review. Respir Res. 2015;16:50. doi:10.1186/s12931-015-0208-4.
- Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014;9:871–888. doi:10.2147/COPD.S49621.
- Spelta F, Fratta Pasini AM, Cazzoletti L, et al. Body weight and mortality in COPD: focus on the obesity paradox. Eat Weight Disord. 2018;23(1):15–22. doi:10.1007/s40519-017-0456-z.
- Yamauchi Y, Hasegawa W, Yasunaga H, et al. Paradoxical association between body mass index and in-hospital mortality in elderly patients with chronic obstructive pulmonary disease in Japan. Int J Chron Obstruct Pulmon Dis. 2014;9:1337–1346.
- Stoll P, Foerster S, Virchow JC, et al. Overweight is a predictor of long-term survival in hospitalised patients with exacerbations of COPD. Respir Med. 2016;116:59–62. doi:10.1016/j.rmed.2016.05.016.
- Raad S, Smith C, Allen K. Nutrition status and chronic obstructive pulmonary disease: can we move beyond the body mass index?. Nutr Clin Pract. 2019;34(3):330–339. doi:10.1002/ncp.10306.
- Haahtela T, Tuomisto LE, Pietinalho A, et al. A 10 year asthma programme in Finland: major change for the better . Thorax. 2006;61(8):663–670. doi:10.1136/thx.2005.055699.
- Kauppi P, Linna M, Martikainen J, et al. Follow-up of the Finnish Asthma Programme 2000-2010: reduction of hospital burden needs risk group rethinking. Thorax. 2013;68(3):292–293. doi:10.1136/thoraxjnl-2011-201028.
- Kinnula V, Vasankari T, Kontula E, et al. The 10-year COPD programme in Finland: effects on quality of diagnosis, smoking, prevalence, hospital admissions and mortality. Prim Care Respir J. 2011;20(2):178–183. doi:10.4104/pcrj.2011.00024.